Day two of the J.P Morgan Healthcare Conference rolled on with positive data from Sling Therapeutics Inc. that is leading the company to a phase III study in treating thyroid eye disease. The ...

High-yield dividend stocks may not appeal to some investors. However, if you're among those investors looking for income, ...

AbbVie’s mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable ...

AbbVie Inc. discovers, develops ... Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations ...

Please provide your email address to receive an email when new articles are posted on . Adults who lose a substantial amount of weight with obesity treatment lose more fat mass than fat-free mass ...

American drug major AbbVie Healthcare’s Indian arm, which is under the scanner for sponsoring foreign trips of 30 doctors in violation of the Uniform Code for Pharmaceutical Marketing Practices (UCPMP ...

Experts share thyroid myths to stop believing now. 1. Myth: If you have unexplained weight gain and fatigue, it’s most likely a thyroid problem. Mythbuster: While these symptoms can point to a ...

ABBV-932 is under clinical development by AbbVie and currently in Phase I for Schizophrenia. According to GlobalData, Phase I drugs for Schizophrenia have a 66% phase transition success rate (PTSR) ...

The Apex Committee for Pharma Marketing Practices has found Abbvie Healthcare India Private Ltd in breach of the UCPMP ( Uniform Code for Pharmaceutical Marketing Practices), by sponsoring ...

The department of pharmaceuticals (DoP) reprimanded AbbVie Healthcare India for unethical marketing practices involving over ₹1 crore spent on foreign vacations for 30 doctors under the guise of ...

AbbVie (NYSE: ABBV) and Amgen (NASDAQ ... the only medicine approved by the U.S. Food and Drug Administration for thyroid eye disease. The biotech giant could milk Tepezza in ways the smaller ...